Bigdeli, T B
Ripke, S
Peterson, R E
Trzaskowski, M
Bacanu, S-A
Abdellaoui, A
Andlauer, T F M
Beekman, A T F
Berger, K
Blackwood, D H R
Boomsma, D I
Breen, G
Buttenschøn, H N
Byrne, E M
Cichon, S
Clarke, T-K
Couvy-Duchesne, B
Craddock, N
de Geus, E J C
Degenhardt, F
Dunn, E C
Edwards, A C
Fanous, A H
Forstner, A J
Frank, J
Gill, M
Gordon, S D
Grabe, H J
Hamilton, S P
Hardiman, O
Hayward, C
Heath, A C
Henders, A K
Herms, S
Hickie, I B
Hoffmann, P
Homuth, G
Hottenga, J-J
Ising, M
Jansen, R
Kloiber, S
Knowles, J A
Lang, M
Li, Q S
Lucae, S
MacIntyre, D J
Madden, P A F
Martin, N G
McGrath, P J
McGuffin, P
McIntosh, A M
Medland, S E
Mehta, D
Middeldorp, C M
Milaneschi, Y
Montgomery, G W
Mors, O
Müller-Myhsok, B
Nauck, M
Nyholt, D R
Nöthen, M M
Owen, M J
Penninx, B W J H
Pergadia, M L
Perlis, R H
Peyrot, W J
Porteous, D J
Potash, J B
Rice, J P
Rietschel, M
Riley, B P
Rivera, M
Schoevers, R
Schulze, T G
Shi, J
Shyn, S I
Smit, J H
Smoller, J W
Streit, F
Strohmaier, J
Teumer, A
Treutlein, J
Van der Auwera, S
van Grootheest, G
van Hemert, A M
Völzke, H
Webb, B T
Weissman, M M
Wellmann, J
Willemsen, G
Witt, S H
Levinson, D F
Lewis, C M
Wray, N R
Flint, J
Sullivan, P F
Kendler, K S
,
Article History
Received: 19 November 2016
Accepted: 27 November 2016
First Online: 28 March 2017
Competing interests
: PFS is a scientific advisor to Pfizer. HJG reports receiving funding from the following: German Research Foundation; Federal Ministry of Education and Research Germany; speakers honoraria from, Eli Lilly and Servier. BM-M consulted for Affectis Pharmaceuticals. RP has received consulting fees from Proteus Biomedical, Concordant Rater Systems, Genomind and RID Ventures. The remaining author declare no conflict of interest.